News & Updates

Show Multimedia Only

Low-dose aspirin improves reproductive outcomes in women with pregnancy loss

04 Feb 2021

Preconception use of low-dose aspirin (LDA) at least 4 days per week is associated with better reproductive outcomes for women who have had one or two pregnancy losses, suggests a study. Increasing adherence to daily LDA may help improve effectiveness.

Low-dose aspirin improves reproductive outcomes in women with pregnancy loss

04 Feb 2021

First-line ipatasertib-paclitaxel fails to show PFS benefit in PIK3CA/AKT1/PTEN-altered aTNBC

03 Feb 2021 by

Ipatasertib plus paclitaxel in the first-line setting does not confer a progression-free survival (PFS) benefit to patients with PIK3CA/AKT1/PTEN-altered locally advanced unresectable or metastatic triple-negative breast cancer (aTNBC), according to a study presented at SABCS 2020.

First-line ipatasertib-paclitaxel fails to show PFS benefit in PIK3CA/AKT1/PTEN-altered aTNBC

03 Feb 2021

PCOS carries elevated diabetes risk regardless of obesity status

02 Feb 2021

Women with polycystic ovary syndrome (PCOS) are at risk of developing subsequent type 2 diabetes mellitus (T2DM), even those without obesity, a study reports.

PCOS carries elevated diabetes risk regardless of obesity status

02 Feb 2021

News & Updates

Showing Obstetrics & Gynaecology articles

Showing

Specialty:

Low-dose aspirin improves reproductive outcomes in women with pregnancy loss

Low-dose aspirin improves reproductive outcomes in women with pregnancy loss

First-line ipatasertib-paclitaxel fails to show PFS benefit in PIK3CA/AKT1/PTEN-altered aTNBC

First-line ipatasertib-paclitaxel fails to show PFS benefit in PIK3CA/AKT1/PTEN-altered aTNBC

PCOS carries elevated diabetes risk regardless of obesity status

PCOS carries elevated diabetes risk regardless of obesity status